Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]

GOALS: To evaluate safety and efficacy of Bacillus coagulans LBSC [DSM17654] in irritable bowel syndrome (IBS) through a prospective, interventional, randomized, double-blind, and placebo-controlled, CONSORT compliant clinical trial. BACKGROUND: Bacteriotherapy shows promising impact on alleviating...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anil Kumar, Maity, Chiranjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837859/
https://www.ncbi.nlm.nih.gov/pubmed/33545934
http://dx.doi.org/10.1097/MD.0000000000023641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837859/
https://www.ncbi.nlm.nih.gov/pubmed/33545934
http://dx.doi.org/10.1097/MD.0000000000023641

Ejemplares similares